HT
INBS icon

Headlands Technologies’s Intelligent Bio Solutions INBS Stock Holding History

Headlands Technologies’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$110 – 1353
2024
Q1 		$110 Buy
+3
New +$124 ﹤0.01% 1213

Other funds holding INBS

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Headlands Technologies's INBS Position: Q2 2024 in Review

Headlands Technologies sold out of Intelligent Bio Solutions (INBS) in Q2 2024, closing a stake of 3 shares — an estimated $110 sold.

Headlands Technologies first reported a position in INBS in Q1 2024 and held it in 1 quarter. The position peaked at $110 in Q1 2024. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2024.

  • Headlands Technologies reported no remaining Intelligent Bio Solutions position as of Q2 2024 after selling out during the quarter.
  • Headlands Technologies sold 3 Intelligent Bio Solutions shares in Q2 2024, an estimated $110.
  • Headlands Technologies first reported a position in Intelligent Bio Solutions in Q1 2024 and held it in 1 quarter.
  • Headlands Technologies's Intelligent Bio Solutions position peaked at $110 in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2024.

Based on Headlands Technologies's 13F filing for Q2 2024, filed 7 Aug 2024.